SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017660
Filing Date
2017-08-14
Accepted
2017-08-14 16:28:31
Documents
47
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q 06/30/2017 reta-10q_20170630.htm 10-Q 1309998
2 EX-31.1 reta-ex311_7.htm EX-31.1 18958
3 EX-31.2 reta-ex312_9.htm EX-31.2 18881
4 EX-32.1 reta-ex321_8.htm EX-32.1 10179
5 EX-32.2 reta-ex322_6.htm EX-32.2 10169
6 GRAPHIC g201708141452185768805.jpg GRAPHIC 21067
7 GRAPHIC g201708141452185418804.jpg GRAPHIC 34660
8 GRAPHIC g201708141452187098806.jpg GRAPHIC 18021
  Complete submission text file 0001564590-17-017660.txt   3497240

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT reta-20170630.xml EX-101.INS 464081
10 XBRL TAXONOMY EXTENSION SCHEMA reta-20170630.xsd EX-101.SCH 25253
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20170630_cal.xml EX-101.CAL 31372
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20170630_def.xml EX-101.DEF 89299
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20170630_lab.xml EX-101.LAB 212429
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20170630_pre.xml EX-101.PRE 167778
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 171030639
SIC: 2834 Pharmaceutical Preparations